ImageneBio

Health Care · Immunology & Inflammation Therapeutics

Overview

ImageneBio is a clinical-stage biotechnology company developing therapeutics for patients who have immunological, autoimmune and inflammatory diseases. IMG-007 is our next-generation investigational anti-OX40 monoclonal antibody.

Key facts

These are the key facts about ImageneBio on Alion as of Nov 13, 2026. ImageneBio is headquartered in Boston, United States. The latest round is Venture - Series Unknown of $42.6M, announced in 2023.

Headquarters
Boston, United StatesAlion company profile, updated Sep 27, 2026
Employees
200+Alion company profile, an estimated range
Total raised
$42.6MSum of 1 equity round Alion knows
Latest round
Venture - Series Unknown · $42.6M · Aug 4, 2023SEC Form D filing · sec.gov
Official records

Financials

Total raised
$42.6M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2023 $42.6M Details

People

Sergio Santillana
Executive Officer
SEC Form D
Michelle Zhang
Executive Officer
SEC Form D
Jotin Marango
Executive Officer
SEC Form D
Jeffrey Ecsedy
Executive Officer
SEC Form D
Mark Manfredi
Executive Officer, Director
SEC Form D
Maria Koehler
Director
SEC Form D
Richard Wooster
Director
SEC Form D
Iain Dukes
Director
SEC Form D
Owen Hughes
Director
SEC Form D
Otello Stampacchia
Director
SEC Form D
Jean-Francois Formela
Director
SEC Form D
David Bonita
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors5
Atlas VentureVia a fund
55 portfolio companies: Show + Tell, LifeSciVC, Vima Therapeutics and 52 more
Vertex Ventures ChinaVia a fund
102 portfolio companies: Lightelligence, NuVolta Technologies (Hefei), Arcfra and 99 more
Foresite CapitalVia a fund
131 portfolio companies: Veracyte, UpDoc, Zura Bio and 128 more
Omega FundsVia a fund
160 portfolio companies: Windward Bio, Xiimedical, Xtuit and 157 more
OrbiMedVia a fund
196 portfolio companies: Cookiedatabase.org, ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., Z-Alpha Therapeutics and 193 more
Show all 5
Report a mistake

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Boston United States
HQ
200-500 est. staff

How to cite this page

Alion, "ImageneBio: key facts", as of Nov 13, 2026. https://alion.io/company/imagenebio

These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0